(Updated March 12, 2017) MD Stem Cells has announced a new and extensive stem cell study to determine effectiveness of stem cells in ophthalmic disease. The company has been named collaborator for the new Stem Cell Ophthalmology Treatment Study (SCOTS), being conducted in Florida. Conditions eligible for the new study include retinal diseases such as age-related [Read More]
